Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
clinical trial data
Biotech
Boehringer's phase 3 lung fibrosis trial hits primary endpoint
Boehringer has ended a decade of industrywide failures in idiopathic pulmonary fibrosis with a phase 3 win for a potentially first-in-class drug.
Nick Paul Taylor
Sep 16, 2024 8:30am
ESMO: Bristol Myers axes Immatics' bispecific after $150M bet
Sep 16, 2024 6:59am
ESMO: Pfizer sees weight gain in cancer patients, plots ph. 3
Sep 14, 2024 8:45am
ESMO: AstraZeneca posts data on ADC rivals to AbbVie, Pfizer
Sep 14, 2024 3:00am
Novo hails ‘remarkable’ weight loss result for experimental pill
Sep 11, 2024 11:02am
BridgeBio cuts gene therapy budget as clinical data disappoint
Sep 11, 2024 7:50am